153 related articles for article (PubMed ID: 31677824)
1. Understanding the Value of Tumor Markers in Pediatric Ovarian Neoplasms.
Lawrence AE; Fallat ME; Hewitt G; Hertweck P; Onwuka A; Afrazi A; Bence C; Burns RC; Corkum KS; Dillon PA; Ehrlich PF; Fraser JD; Gonzalez DO; Grabowski JE; Kabre R; Lal DR; Landman MP; Leys CM; Mak GZ; Overman RE; Rademacher BL; Raiji MT; Sato TT; Scannell M; Sujka JA; Wright T; Minneci PC; Deans KJ; Aldrink JH;
J Pediatr Surg; 2020 Jan; 55(1):122-125. PubMed ID: 31677824
[TBL] [Abstract][Full Text] [Related]
2. Selecting treatment method for ovarian masses in children - 24 years of experience.
Łuczak J; Bagłaj M
J Ovarian Res; 2017 Sep; 10(1):59. PubMed ID: 28893324
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic accuracy of preoperative alpha-fetoprotein as an ovarian tumor marker in children and adolescents: not as good as we thought?
Loh AH; Gee KW; Chua JH
Pediatr Surg Int; 2013 Jul; 29(7):709-13. PubMed ID: 23653236
[TBL] [Abstract][Full Text] [Related]
4. The search for biomarkers of metastatic seminoma.
Ruf CG; Khalili-Harbi N; Sachs S; Isbarn H; Wagner W; Matthies C; Meineke V; Fisch M; Chun FK; Abend M
J Urol; 2013 Sep; 190(3):1046-51. PubMed ID: 23583226
[TBL] [Abstract][Full Text] [Related]
5. Ovarian masses in children and adolescents - an analysis of 521 clinical cases.
Zhang M; Jiang W; Li G; Xu C
J Pediatr Adolesc Gynecol; 2014 Jun; 27(3):e73-7. PubMed ID: 24157281
[TBL] [Abstract][Full Text] [Related]
6. Multi-Institutional Review of the Preoperative Diagnostic Accuracy for Pediatric Ovarian Mature Cystic Teratomas.
Knaus ME; Onwuka AJ; Afrazi A; Breech L; Corkum KS; Dillon PA; Ehrlich PF; Fallat ME; Fraser JD; Gadepalli SK; Grabowski JE; Hertweck SP; Kabre R; Lal DR; Landman MP; Lawrence AE; Leys CM; Mak GZ; Markel TA; Merchan N; Overman RE; Rademacher BL; Raiji MT; Rymeski B; Sato TT; Scannel M; Schikler AG; Sujka JA; Wright T; Aldrink JH; Hewitt GD; Minneci PC; Deans KJ;
J Pediatr Adolesc Gynecol; 2022 Aug; 35(4):478-485. PubMed ID: 35124214
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic Performance of Magnetic Resonance Imaging for Pediatric Ovarian Neoplasms: A Multi-Institutional Review.
Bergus KC; Knaus ME; Onwuka AJ; Afrazi A; Breech L; Corkum KS; Dillon PA; Ehrlich PF; Fallat ME; Fraser JD; Gadepalli SK; Grabowski JE; Hertweck SP; Kabre R; Lal DR; Landman MP; Leys CM; Mak GZ; Markel TA; Merchant N; Overman RE; Rademacher BL; Raiji MT; Rymeski B; Sato TT; Wright T; Aldrink JH; Hewitt GD; Minneci PC; Deans KJ;
J Pediatr Adolesc Gynecol; 2024 Apr; 37(2):192-197. PubMed ID: 38008283
[TBL] [Abstract][Full Text] [Related]
8. A Preoperative Scoring System for Adnexal Mass in Children and Adolescents to Preserve Their Future Fertility.
Depoers C; Martin FA; Nyangoh Timoh K; Morcet J; Proisy M; Henno S; Lavoue V; Arnaud AP
J Pediatr Adolesc Gynecol; 2019 Feb; 32(1):57-63. PubMed ID: 30205159
[TBL] [Abstract][Full Text] [Related]
9. Serum tumour markers in gynaecological cancers.
Aggarwal P; Kehoe S
Maturitas; 2010 Sep; 67(1):46-53. PubMed ID: 20510555
[TBL] [Abstract][Full Text] [Related]
10. Pre-operative differentiation of pediatric ovarian tumors: morphological scoring system and tumor markers.
Stankovic ZB; Djukic MK; Savic D; Lukac BJ; Djuricic S; Sedlecki K; Zdravkovic D
J Pediatr Endocrinol Metab; 2006 Oct; 19(10):1231-8. PubMed ID: 17172084
[TBL] [Abstract][Full Text] [Related]
11. A case of pediatric ovarian dysgerminoma associated with high serum levels and positive immunohistochemical staining of neuron-specific enolase.
Tatekawa Y; Kemmotsu H; Mouri T; Joe K; Ohkawa H
J Pediatr Surg; 2004 Sep; 39(9):1437-9. PubMed ID: 15359410
[TBL] [Abstract][Full Text] [Related]
12. Factors Associated With Management of Pediatric Ovarian Neoplasms.
Lawrence AE; Gonzalez DO; Fallat ME; Aldrink JH; Hewitt GD; Hertweck SP; Onwuka A; Bence C; Burns RC; Dillon PA; Ehrlich PF; Fraser JD; Grabowski JE; Hirschl RB; Kabre R; Kohler JE; Lal DR; Landman MP; Leys CM; Mak GZ; Sato TT; Scannell M; Sujka JA; Minneci PC; Deans KJ
Pediatrics; 2019 Jul; 144(1):. PubMed ID: 31164439
[TBL] [Abstract][Full Text] [Related]
13. Prediction of pre-eclampsia with maternal mid-trimester total renin, inhibin A, AFP and free beta-hCG levels.
Räty R; Koskinen P; Alanen A; Irjala K; Matinlauri I; Ekblad U
Prenat Diagn; 1999 Feb; 19(2):122-7. PubMed ID: 10215068
[TBL] [Abstract][Full Text] [Related]
14. Combination of serum hCG beta and p53 tissue expression defines distinct subgroups of serous ovarian carcinoma.
Vartiainen J; Lassus H; Lehtovirta P; Finne P; Alfthan H; Butzow R; Stenman UH
Int J Cancer; 2008 May; 122(9):2125-9. PubMed ID: 18098286
[TBL] [Abstract][Full Text] [Related]
15. Serum Levels of MicroRNA-371a-3p (M371 Test) as a New Biomarker of Testicular Germ Cell Tumors: Results of a Prospective Multicentric Study.
Dieckmann KP; Radtke A; Geczi L; Matthies C; Anheuser P; Eckardt U; Sommer J; Zengerling F; Trenti E; Pichler R; Belz H; Zastrow S; Winter A; Melchior S; Hammel J; Kranz J; Bolten M; Krege S; Haben B; Loidl W; Ruf CG; Heinzelbecker J; Heidenreich A; Cremers JF; Oing C; Hermanns T; Fankhauser CD; Gillessen S; Reichegger H; Cathomas R; Pichler M; Hentrich M; Eredics K; Lorch A; Wülfing C; Peine S; Wosniok W; Bokemeyer C; Belge G
J Clin Oncol; 2019 Jun; 37(16):1412-1423. PubMed ID: 30875280
[TBL] [Abstract][Full Text] [Related]
16. Obstetrical complications associated with abnormal maternal serum markers analytes.
Gagnon A; Wilson RD;
J Obstet Gynaecol Can; 2008 Oct; 30(10):918-932. PubMed ID: 19038077
[TBL] [Abstract][Full Text] [Related]
17. Usefulness of beta hCG as tumor marker in the diagnosis and follow up of patients with ovarian cancer.
Djurdjevic S; Maksimovic M; Pantelic M; Golubovic A; Curcic A
J BUON; 2011; 16(4):715-21. PubMed ID: 22331727
[TBL] [Abstract][Full Text] [Related]
18. Tumor markers at the time of recurrence in patients with germ cell tumors.
Trigo JM; Tabernero JM; Paz-Ares L; García-Llano JL; Mora J; Lianes P; Esteban E; Salazar R; López-López JJ; Cortés-Funes H
Cancer; 2000 Jan; 88(1):162-8. PubMed ID: 10618619
[TBL] [Abstract][Full Text] [Related]
19. Inhibins/activins as diagnostic markers for ovarian cancer.
Robertson DM; Stephenson T; Pruysers E; Burger HG; McCloud P; Tsigos A; Groome N; Mamers P; McNeilage J; Jobling T; Healy D
Mol Cell Endocrinol; 2002 May; 191(1):97-103. PubMed ID: 12044923
[TBL] [Abstract][Full Text] [Related]
20. Preoperative serum inhibin levels in patients with ovarian tumors.
El-Shalakany A; Abou-Talib Y; Shalaby HS; Sallam M
J Obstet Gynaecol Res; 2004 Apr; 30(2):155-61. PubMed ID: 15009621
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
